HIMS

MKT CAP:$7B

Hims & Hers Health, Inc.

Market Cap

$7B

Healthcare·Medical - Equipment & Services·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$28.82-$4.59 (-13.74%)

Apr 17, 2026

Company Details

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websi...

CEO

Andrew Dudum

IPO Date

Sep 13, 2019

Website

www.forhims.com

Key Metrics TTM

Revenue

$2.3B

+59.0% YoY

Net Income

$128M

EPS (Diluted)

$0.51

Free Cash Flow

$73M

Revenue / Share

$9.46

Gross Margin

69.7%

Operating Margin

4.6%

Net Margin

5.5%

FCF Margin

3.1%

P/S

2.9x

P/E

52.2x

Earnings Reports

Q1 2026

May 4, 2026

PENDING

FY 2025

Feb 23, 2026

$2.3B+59.0%EPS $0.51

Q4 2025

Feb 23, 2026

$618M+28.4%EPS $0.08

Q3 2025

Nov 3, 2025

$599M+49.2%EPS $0.06

Q2 2025

Aug 4, 2025

$545M+72.6%EPS $0.17

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$101M	$75M	-$17M
Q2 22	$114M	$87M	-$20M
Q3 22	$145M	$114M	-$20M
Q4 22	$167M	$132M	-$12M
Q1 23	$191M	$153M	-$11M
Q2 23	$208M	$170M	-$9M
Q3 23	$227M	$187M	-$9M
Q4 23	$247M	$204M	-$400.0K
Q1 24	$278M	$229M	$10M
Q2 24	$316M	$257M	$11M
Q3 24	$402M	$318M	$22M
Q4 24	$481M	$370M	$19M
Q1 25	$586M	$431M	$58M
Q2 25	$545M	$416M	$27M
Q3 25	$599M	$442M	$12M
Q4 25	$618M	$346M	$13M

Valuation

Quarter	P/S	P/E
Q1 22	3.3x	—
Q2 22	2.6x	—
Q3 22	2.6x	—
Q4 22	2.5x	—
Q1 23	3.5x	—
Q2 23	2.7x	—
Q3 23	1.7x	—
Q4 23	2.2x	—
Q1 24	3.5x	—
Q2 24	4.3x	256.3x
Q3 24	3.2x	39.8x
Q4 24	3.7x	43.7x
Q1 25	3.7x	39.9x
Q2 25	5.5x	57.2x
Q3 25	6.0x	99.1x
Q4 25	3.3x	60.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$19M	-$21M
Q2 22	-$6M	-$8M
Q3 22	$6M	$4M
Q4 22	-$7M	-$9M
Q1 23	$9M	$7M
Q2 23	$17M	$10M
Q3 23	$25M	$19M
Q4 23	$22M	$11M
Q1 24	$26M	$12M
Q2 24	$54M	$48M
Q3 24	$85M	$79M
Q4 24	$86M	$60M
Q1 25	$109M	$50M
Q2 25	-$19M	-$69M
Q3 25	$149M	$91M
Q4 25	$65M	$821.0K

Capital Expenditures

Quarter	CapEx
Q1 22	$1M
Q2 22	$1M
Q3 22	$2M
Q4 22	$3M
Q1 23	$3M
Q2 23	$7M
Q3 23	$6M
Q4 23	$11M
Q1 24	$14M
Q2 24	$6M
Q3 24	$6M
Q4 24	$27M
Q1 25	$59M
Q2 25	$50M
Q3 25	$57M
Q4 25	$64M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+93.7%	+17.4%
Q2 22	+87.1%	+71.3%
Q3 22	+95.3%	+61.9%
Q4 22	+97.4%	+68.3%
Q1 23	+88.3%	+70.9%
Q2 23	+83.1%	+62.4%
Q3 23	+56.5%	+42.7%
Q4 23	+47.5%	+38.1%
Q1 24	+45.8%	+32.8%
Q2 24	+51.8%	+40.3%
Q3 24	+77.1%	+61.2%
Q4 24	+95.1%	+87.2%
Q1 25	+110.7%	+96.9%
Q2 25	+72.6%	+70.1%
Q3 25	+49.2%	+54.9%
Q4 25	+28.4%	+30.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$9M	8.7%
Q2 22	$11M	9.4%
Q3 22	$11M	7.6%
Q4 22	$12M	7.4%
Q1 23	$14M	7.4%
Q2 23	$17M	8.1%
Q3 23	$17M	7.6%
Q4 23	$18M	7.2%
Q1 24	$19M	6.8%
Q2 24	$24M	7.6%
Q3 24	$25M	6.2%
Q4 24	$24M	5.1%
Q1 25	$25M	4.2%
Q2 25	$36M	6.6%
Q3 25	$40M	6.7%
Q4 25	$34M	5.6%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 22	$6M	$22M	$48M	—
Q2 22	$7M	$23M	$60M	—
Q3 22	$8M	$26M	$78M	—
Q4 22	$8M	$50M	$86M	—
Q1 23	$11M	$31M	$97M	—
Q2 23	$12M	$31M	$107M	—
Q3 23	$12M	$36M	$116M	—
Q4 23	$13M	$32M	$126M	—
Q1 24	$15M	$35M	$131M	—
Q2 24	$19M	$41M	$145M	—
Q3 24	$21M	$45M	$182M	—
Q4 24	$24M	$48M	$221M	—
Q1 25	$30M	$49M	$231M	—
Q2 25	$38M	$67M	$218M	—
Q3 25	$41M	$81M	$232M	—
Q4 25	$41M	—	—	$293M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$48M	$155M	$203M
Q2 22	$55M	$140M	$195M
Q3 22	$58M	$140M	$198M
Q4 22	$47M	$133M	$180M
Q1 23	$49M	$136M	$184M
Q2 23	$65M	$128M	$193M
Q3 23	$58M	$155M	$212M
Q4 23	$97M	$124M	$221M
Q1 24	$105M	$98M	$204M
Q2 24	$129M	$98M	$227M
Q3 24	$166M	$89M	$254M
Q4 24	$221M	$80M	$300M
Q1 25	$274M	$49M	$323M
Q2 25	$1.1B	$20M	$1.1B
Q3 25	$346M	$284M	$630M
Q4 25	$229M	$349M	$577M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	203M	+0.7%	+32.4%
Q2 22	204M	+0.6%	+6.3%
Q3 22	205M	+0.6%	+2.6%
Q4 22	206M	+0.4%	+2.4%
Q1 23	207M	+0.5%	+2.2%
Q2 23	208M	+0.6%	+2.2%
Q3 23	210M	+0.8%	+2.4%
Q4 23	210M	-0.2%	+1.7%
Q1 24	229M	+9.4%	+10.7%
Q2 24	235M	+2.4%	+12.7%
Q3 24	235M	+0.1%	+11.9%
Q4 24	241M	+2.4%	+14.8%
Q1 25	247M	+2.4%	+7.5%
Q2 25	257M	+4.1%	+9.4%
Q3 25	249M	-3.2%	+5.8%
Q4 25	248M	-0.2%	+3.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$254.6K	398
Q2 22	$285.3K	398
Q3 22	$363.9K	398
Q4 22	$256.8K	651
Q1 23	$293.0K	651
Q2 23	$319.4K	651
Q3 23	$348.2K	651
Q4 23	$235.8K	1K
Q1 24	$265.9K	1K
Q2 24	$301.8K	1K
Q3 24	$383.9K	1K
Q4 24	$293.9K	2K
Q1 25	$358.0K	2K
Q2 25	$332.8K	2K
Q3 25	$365.9K	2K
Q4 25	$253.0K	2K

Revenue / Employee